uniQure N.V.’s filing revealed that its Chief Medical Officer Abi-Saab Walid unloaded Company’s shares for reported $6309.0 on Jun 26 ’24. In the deal valued at $4.36 per share,1,447 shares were sold. As a result of this transaction, Abi-Saab Walid now holds 115,253 shares worth roughly $0.46 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, CALOZ PIERRE sold 2,936 shares, generating $14,122 in total proceeds. Upon selling the shares at $4.81, the Chief Operating Officer now owns 115,707 shares.
Before that, KLEMT CHRISTIAN sold 1,611 shares. uniQure N.V. shares valued at $7,733 were divested by the Chief Financial Officer at a price of $4.80 per share. As a result of the transaction, KLEMT CHRISTIAN now holds 164,837 shares, worth roughly $0.66 million.
Goldman downgraded its uniQure N.V. [QURE] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Mizuho’s analysts, who decreased its forecast for the stock in mid December from “a Buy” to “a Neutral”. UBS also remained covering QURE and has increased its forecast on March 17, 2022 with a “Buy” recommendation from previously “Neutral” rating. BTIG Research started covering the stock on June 15, 2021. It rated QURE as “a Buy”.
Price Performance Review of QURE
On Tuesday, uniQure N.V. [NASDAQ:QURE] saw its stock fall -9.79% to $4.01. Over the last five days, the stock has lost -10.09%. uniQure N.V. shares have fallen nearly -40.77% since the year began. Nevertheless, the stocks have fallen -65.01% over the past one year. While a 52-week high of $11.95 was reached on 01/02/24, a 52-week low of $4.25 was recorded on 07/02/24. SMA at 50 days reached $4.81, while 200 days put it at $5.80. A total of 1.11 million shares were traded, compared to the trading of 0.44 million shares in the previous session.
Levels Of Support And Resistance For QURE Stock
The 24-hour chart illustrates a support level at 3.82, which if violated will result in even more drops to 3.64. On the upside, there is a resistance level at 4.31. A further resistance level may holdings at 4.62. The Relative Strength Index (RSI) on the 14-day chart is 27.04, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.31, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.48%. Stochastics%K at 10.12% indicates the stock is a buying.
The most recent change occurred on May 21, 2021 when UBS began covering the stock and recommended ‘”a Neutral”‘ rating along with a $40 price target.
